Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Degludec And Liraglutide: 2 Drivers Of Novo Nordisk's Growth
Seeking Alpha
Tuesday, November 13, 2012 - 12:11pm
tags:
diabetes, degludec, liraglutide, Novo Nordisk, Victoza
Bed Bugs Dying After Merck Drug Suggests Possible Weapon
Bloomberg
Tuesday, November 13, 2012 - 12:10pm
tags:
Merck, bed bugs, Stromectol
Why Nektar Therapeutics' Shares Tumbled
Motley Fool
Tuesday, November 13, 2012 - 12:09pm
tags:
Nektar, AstraZeneca, Naloxegol
3 Reasons Why Not All Hep C Data Is Created Equal
Motley Fool
Tuesday, November 13, 2012 - 11:51am
tags:
hepatitis C, Gilead, Abbott Labs, Vertex Pharmaceuticals, Achillion, Idenix
A Dismal 2012 May Make For A Good Entry Now For AEterna Zentaris
Seeking Alpha
Tuesday, November 13, 2012 - 11:49am
tags:
Aeterna Zentaris
Bayer to test Xarelto in heart attack prevention
Reuters
Tuesday, November 13, 2012 - 11:48am
tags:
Bayer, Xarelto, heart attacks
Merck ceases diabetes-cholesterol pill development
Marketwatch
Tuesday, November 13, 2012 - 11:47am
tags:
MK-0524B, MK-0431E, diabetes, Januvia, Merck
J&J Ponders Elan Tie While Alzheimer Drug Future Reviewed
Bloomberg
Tuesday, November 13, 2012 - 11:43am
tags:
Elan, JNJ, Alzheimer's disease, bapineuzumab
Least-experienced doctors are highest spenders: US study
Pharma Times, UK
Tuesday, November 13, 2012 - 11:43am
tags:
physicians
Cumberland Settles Patent Suit Over Generic Acetadote
Bloomberg
Tuesday, November 13, 2012 - 11:17am
tags:
generics, patents, Acetadote, Cumberland, Perrigo, InnoPharma
Amarin's Dilemma: Sell Vascepa Or Sell Itself?
Seeking Alpha
Tuesday, November 13, 2012 - 11:16am
tags:
Amarin, Vascepa
Pfizer filing shows drugmaker to resolve several lawsuits over its products for about $825 M
Yahoo/AP
Tuesday, November 13, 2012 - 11:15am
tags:
Pfizer, settlements, Rapamune, Celebrex, Pristiq, Protonix, Zyvox, Lyrica
Gilead Shares Hit All-Time High On Positive Trial For Hep C Drug
Yahoo/Investors Business Daily
Tuesday, November 13, 2012 - 11:13am
tags:
hepatitis C, Gilead, GS-5885, GS-7977
2 Reasons You Should Love This Biotech's Good News
Motley Fool
Tuesday, November 13, 2012 - 11:12am
tags:
Celgene, pancreatic cancer, Abraxane
Bristol-Myers Hepatitis C Combo Therapy Shows Promise
Bloomberg
Tuesday, November 13, 2012 - 11:11am
tags:
hepatitis C, Bristol-Myers Squibb, BMS-791325, asunaprevir, declatasvir
Sequenom climbs after analyst sees progress on reimbursements
Yahoo/Fly on the Wall
Monday, November 12, 2012 - 12:38pm
tags:
Sequenom, Downs Syndrome, T21 LDT
Foundation Medicine, AstraZeneca ink cancer genomics pact
Fierce Biotech
Monday, November 12, 2012 - 12:32pm
tags:
Foundation Medicine, AstraZeneca, genomics
Novartis touts new data on Certican, Ilaris
Fierce Pharma
Monday, November 12, 2012 - 12:28pm
tags:
Certican, Ilaris, Novartis
Watson to sell generic version of Pfizer's Revatio
Yahoo/AP
Monday, November 12, 2012 - 12:25pm
tags:
Pfizer, generics, Watson Pharmaceuticals, Revatio, pulmonary arterial hypertension, PAH
Seattle Genetics: A Short Thesis That's Been Right And Wrong
TheStreet.com
Monday, November 12, 2012 - 11:41am
tags:
Seattle Genetics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.